Testing effectiveness (Phase 2)Study completedNCT00632242
What this trial is testing
ARC1779 Injection in Patients With Von Willebrand Factor-Related Platelet Function Disorders
Who this might be right for
Purpura, Thrombotic ThrombocytopenicVon Willebrand Disease Type-2b
Archemix Corp. 28